Money Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market 2 mins read Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales
Relief for Gujaratis, good news about bringing American visa, know what is the new guideline 1 min read